Bioniq

Bioniq belongs to Dr. Wolff-Gruppe GmbH through Dr. Kurt Wolff GmbH & Co. KG. Bioniq is owned by Dr. Wolff-Gruppe GmbH, headquartered in Germany. No. The ultimate owner of Bioniq, Dr. Wolff-Gruppe GmbH, is headquartered in Germany, not in the United States.

Bioniq AG is a Swiss health technology company specializing in personalized nutritional supplements. They utilize a proprietary database of over 6 million biochemical data points and an advanced algorithm to create customized supplement formulas tailored to individual health profiles. Their products are Swiss-made, pharmaceutical-grade, and utilize precise micro-dosing to address bio-individual needs and deficiencies. Bioniq has partnerships with major sports and health institutions, including the UFC and Lanserhof, and is the preferred choice of many top athletes. Cristiano Ronaldo is a notable investor and shareholder in Bioniq, reinforcing his belief in the company's mission. The company has experienced significant growth, with its user base increasing more than fivefold in 2024, and its products are now sold in over 70 countries. Bioniq's offerings include personalized supplements, blood testing services, and a mobile app for health management. They emphasize a data-driven approach to health optimization, providing users with tailored solutions based on their unique health data and goals.